EUCTR2008-006153-41-AT进行中(未招募)1 期
Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection
Medical university Graz, Department of Plastic Surgery0 个研究点开始时间: 2009年2月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Written informed consent to participate in the study
- •2. Male or female patient of 18 years of age or older
- •3. Patient suffers from documented diabetes and soft tissue infection of the lower limb complicated by osteomyelitis
- •4. Patient requires surgical debridement with bone resection and intravenous anti-microbial therapy
- •5. Negative urine pregnancy test in females of childbearing potential
- •6. Patient is willing to participate in the study, follow protocol study treatment regimen, and comply with all planned assessments.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Treatment with the study drug within the past three weeks prior to study enrolment.
- •2. Relevant renal dysfunction indicated by a creatinine clearance = 40 ml/min as determined by the Cockcroft-Gault equation using actual body weight (Appendix 4).
- •3. Severe hepatic impairment defined by a serum AST = 150.
- •4. Neutrophil count <1000/µl
- •5. Thrombocytopenia < 50 000 /µl
- •6. HIV, HCV or HBV infection.
- •7. History of hypersensitivity to the study drug or to drugs with similar chemical structures (oxazolidinones).
- •8. Treatment with antidepressants belonging to the class of selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and noradrenalin reuptake inhibitors (SNRIs)
- •9. Patients submitted to the hospital with known pathogens resistant to study drug
- •10. Use of any other investigational therapy at the time of enrolment, or within 30 days.
- •11. Patients unable or unwilling to adhere to the study-designated procedures and restrictions.
- •12. Unable to understand the nature, purpose and extent of the study
- •13. Breast-feeding woman
研究者
相似试验
进行中(未招募)
不适用
Target site pharmacokinetics of linezolid after single and multiple doses in diabetes patients with soft tissue infectiodiabetic patients with soft tissue infection, necessiting antibiotic therapyEUCTR2007-007958-54-ATDepartment of Clinical Pharmacology, Medical University of Vienna
进行中(未招募)
不适用
Target site pharmacokinetics of linezolid or tigecycline in patients with severe skin and skin structure infections (SSSI) associated with chronic fistulas. - Fistula-SD-MDEUCTR2011-000064-10-ATMed. Univ. Wien, Klinik für klinische Pharmakologie20
进行中(未招募)
不适用
Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysisSepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.EUCTR2013-000899-16-DEDepartment of Pharmacy Unversitätsmedizin Mainz
尚未招募
4 期
pharmacokinetics and toxicity of linezolid in MDR-TB patientstuberculosis MDR-TB10028440NL-OMON29905niversitair Medisch Centrum Groningen10
进行中(未招募)
1 期
Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) - LINUSEUCTR2006-002338-39-DEniversitätsklinikum Heidelberg15
